falsefalse

My Treatment Approach: My Treatment Approach: Navigating Genetic Testing and RET-Targeted Treatments in NSCLC - Episode 11

Monitoring Patients With RET-Positive NSCLC

,

Panelists discuss how to monitor patients for response to treatment and early signs of resistance in RET fusion–positive non–small cell lung cancer (NSCLC), including the approach to follow-up molecular testing, and describe strategies for treatment sequencing after disease progression on RET inhibitors.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    1. Dr Sands to Dr Wakelee: How do you monitor patients for response to treatment and early signs of resistance?
      1. What is your approach to follow-up molecular testing?
    2. Dr Wakelee: Describe your approach to treatment sequencing after disease progression on RET inhibitors.
    x